1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer (Q39616383)

From Wikidata
Jump to navigation Jump to search
scientific article published on 21 December 2010
edit
Language Label Description Also known as
English
1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer
scientific article published on 21 December 2010

    Statements

    1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer (English)
    Isabelle Clinckspoor
    Lieve Verlinden
    Lutgart Overbergh
    Christopher Korch
    Annemieke Verstuyf
    Brigitte Decallonne
    21 December 2010
    1-2

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit